Evidently, our results clearly displayed that MAGL-inhibitor JZL184 could inhibit upregulation, phosphorylation, and nuclear translocation of NF-kB p65 in HCC cells, which means that MAGL overexpression could promote the activity of NF-kB p65 in HCC cells. Here, MGLL is linked to hepatocellular carcinoma.